medigraphic.com
ISSN 0035-0052 (Impreso)

2011, Número S1

Rev Mex Pediatr 2011; 78 (S1)


Guía de práctica clínica: Tratamiento del síndrome de dificultad respiratoria neonatal

Ballesteros OJC, Udaeta ME, Villegas SR, Cardiel ML, Fernández CLA, Flores NG, Lemus VML, López CC, Orozco GA, Osorno CL, Ramírez VJM, Robledo GAE, Rodríguez WMÁ, Vargas OA, Vizuett MR, Mendiola FL, Jiménez GGA

Idioma: Español
Referencias bibliográficas: 117
Paginas: 3-25
Archivo PDF: 162.09 Kb.


RESUMEN

La supervivencia de un número cada vez mayor de neonatos prematuros que sufren síndrome de dificultad respiratoria ha ocasionado un incremento en su morbilidad y mortalidad a pesar del avance en los procedimientos diagnósticos y terapéuticos aplicados con diversos criterios, de acuerdo al nivel de conocimiento y de atención en las unidades de cuidados intensivos neonatales. Por esto, para mejorar y estandarizar los criterios de tratamiento del recién nacido con SDRn, se ha reunido un grupo de expertos para elaborar una guía de práctica clínica adaptada a nuestro medio, conforme a los criterios de la medicina basada en evidencia para su difusión nacional, aplicación e impacto en un mejor pronóstico para la vida y la función de los recién nacidos pretérmino.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Shekelle P, Wolf S, Eccles M, Grimshaw J. Clinical guidelines. Developing guidelines. BMJ 1999; 3(18): 593-659.

  2. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, Saugstad OD, Simeoni U, Speer CP, Halliday HL. European Consensus Guidelines on the management of neonatal respiratory distress syndrome in preterm infants – 2010 Update. Neonatology 2010; 97: 402-17. DOI: 10.1159/000297773.

  3. Guía Clínica. Síndrome de dificultad respiratoria en el recién nacido. Ministerio de Salud de la República de Chile, 2006.

  4. Guía de práctica clínica del diagnóstico y tratamiento del síndrome de dificultad respiratoria en el recién nacido. México; Instituto Mexicano del Seguro Social 2009.

  5. The AGREE Collaboration. Evaluación de guías de práctica clínica. Instrumento AGREE. 2001. Disponible en: http://www.agreecollaboration.org

  6. Cerón HA, Viniegra OA, Torres AL, Valenzuela FA. Manual para la adopción y adaptación de guías de práctica clínica. IMSS 2007.

  7. Aladangady N, McHugh S, Aitchison TC, Wardrop CAJ, Holland BM. Infants’ blood volume in a controlled trial of placental transfusion at preterm delivery. Pediatrics 2006; 117: 93-8.

  8. Perlman JM, Risser R. Cardiopulmonary resuscitation in the delivery room: associated clinical events. Arch Pediatr Adolesc Med 1995; 149: 20-5.

  9. Barber CA, Wyckoff MH. Use and efficacy of endotracheal versus intravenous epinephrine during neonatal cardiopulmonary resuscitation in the delivery room. Pediatrics 2006; 118: 1028-34.

  10. Perlman JM, Wyllie J, Kattwinkel J, Atkins DL, Richmond LS, Simon WM, Singhal N, Szyld E, Tamura M, Chameides L, Goldsmith JP, Guinsburg R, Hazinski MF, Morley C, Velaphi S, and Neonatal resuscitation chapter collaborators. Part 11: Neonatal resuscitation: 2010 International consensus o cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation 2010; 122: S516-S538.

  11. Askie LM, Henderson-Smart DJ. Restricted oxygen exposure versus liberal exposure for the prevention of morbidity and mortality in premature newborns and/or low-birth weight babies. Cochrane Database Syst Rev 2006; (2): CD001077.

  12. Saugstad OD, Ramji, Soll RF, Vento M. Resuscitation of newborn infants with 21% o 100% oxygen: an updated systematic review and meta-analysis. Neonatology 2008; 94: 176-82.

  13. Lundstrom KE, Pryds O, Greisen G. Oxygen at birth and prolonged cerebral vasoconstriction in preterm infants. Arch Dis Child Fetal Neonatal Ed 1995; 3: F81-6.

  14. Wang CL, Anderson C, Leone TA, Rich W, Govindaswani B, Finer NN. Resuscitation of preterm neonate by using room air or 100% oxygen. Pediatrics 2008; 121: 1083-89.

  15. Escrig R, Arruza L, Izquierdo I, Villar G, Saenz P, Gimeno A, Moro M, Vento M. Achievement of targeted saturation values in extremely low gestational age neonates resuscitated with low or high oxygen concentration: a prospective randomized trial. Pediatrics 2008; 121: 875-81.

  16. Vento M, Moro M, Escrig R, Arruza L, Villar D, Izquierdo I et al. Preterm resuscitation with low oxygen causes less oxidative stress, inflammation and chronic lung disease. Pediatrics 2009; 124: e439-49.

  17. McCall EM, Alderlice FA, Halliday HL, Jenkins JG, Vohra S. Interventions to prevent hypothermia at birth in preterm and/or low birth weight babies. Cochrane Databse of Syst Rev 2005; (1): CD004210.

  18. Sinclair JC. Servocontrol para mantener a 36 ºC la temperatura de la piel del abdomen en lactantes de bajo peso al nacer (Revisión. Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 2. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2008 Issue 2. Chichester, UK: John Wiley & Sons, Ltd.).

  19. Perinatal continuing educational program (PCEP), Libro 3. Neonatal Care. American Academy of Pediatrics. Universidad de Virginia. 2009.

  20. Soll RF. Heath loss prevention in neonates. Journal of Perinatology 2008; 28: S57-S59.

  21. Silverman WA, Fertig JW, Berger AP. The influence of the thermal environment upon the survival of newly born premature infants. Pediatrics 1958; 22(5): 876-86.

  22. Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Sys Rev Issue 4, 2009.

  23. Hartnoll G, Betremieux P, Modi N. Randomized controlled trial of postnatal sodium supplementation in infants of 25-30 weeks gestational age: effects on cardiopulmonary adaptation. Arch Dis Child Fetal Neonatal 2001; 85: f29-f32.

  24. Canadian Pediatric Society, Fetus and Newborn Committee. Screening guidelines for newborns at risk for low blood glucose. Pediatric Child Health 2004; 9: 723-9. Reaffirmed feb 2009. IV.

  25. Thureen PJ, Hay WW. Neonatal nutrition and metabolism. 2ª ed. Cambridge University Press, 2006. Cap. 35.

  26. DeMarie MP, Hoffenberg A, Biggerstaff SL, et al. Determinants of energy expenditure in ventilated preterm infants. J Perinat Med 1999; 27: 465-72.

  27. Ehrenkranz RA. Early aggressive nutritional management for very low birth weight infants is the evidence? Sem Perinatol 2007; 31: 48-55.

  28. Ekhard E, Ziegler MD, Patti JT. Aggressive nutrition of the very low birthweight infant. Clin Perinatol 2002; 29: 225-44.

  29. Ibrahim HM, Jeroudi MA, Baier RJ, Dhanireddy R, Krouskop RW. Aggressive early total parenteral nutrition in low-birth-weight infants. J Perinatology 2004; 24: 482-6.

  30. Wilson DC, Cairns P, Halliday HL, Reid M, McClure G, Dodge JA. Randomized controlled trial of an aggressive nutritional regimen in sick very low birthweight infants. Arch Dis Child 1997; 77: F4-F11.

  31. Dinerstein A, Neito RM, Solana CL. Early and aggressive nutritional strategy (parenteral and enteral) decreases postnatal growth failure in very low birth weight infants. J Perinatology 2006; 26: 436-42.

  32. Tyson JE, Kennedy KA. Trophic feedings for parenterally fed infants. Cochrane Database Syst Rev Issue 3, 2005.

  33. Kennedy KA, Tyson JE. Early versus delayed Initiation of progressive enteral feedings for parenterally fed low birth weight or preterm infants. Cochrane Database Syst Rev Issue 4, 2004.

  34. Kennedy KA, Tyson JE. Rapid versus slow rate of advance ment of feedings for promoting growth and preventing necrotizing enterocolitis in parenterally fed low-birth-weight infants. Cochrane Database Syst Rev Issue 2, 2005.

  35. Premji SS, Fenton TR, Sauve RS. Ingesta alta versus baja de proteínas en lactantes con bajo peso al nacer alimentados con leche de fórmula (Revisión Cochrane traducida) En: La Biblioteca Cochrane Plus, 2008 Número 2. Oxford: Update software Ltd.

  36. Mihatsch WA, von Schoenaich P, Fahenestich H, Dehne N, Ebbecke H, Plath C, von Stockhausen HB, Muche R, Franz A, Pohlabdt F. The significance of gastric residuals in the early enteral feeding advancement of extremely low birth weight infants. Pediatrics 2002; 109: 457-9.

  37. Roberts D, Dalziel S. Corticosteroides prenatales para la aceleración de la maduración del pulmón fetal en mujeres con riesgo de parto prematuro (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 2. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2008 Issue 2. Chichester, UK: John Wiley & Sons, Ltd.). Fecha de la modificación significativa más reciente: 15 de mayo de 2006.

  38. Stevens TP, Blennow M, Myers EH, Soll R. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database of Systematic Reviews 2009; 4: CD003063.

  39. 39 Engle WA and the Committee on fetus and Newborn. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008: 121: 419-31.

  40. Sweet D, Bevilacqua G, Carnielli V, Greisen G, Plavka R, Saugstad OD, Simeoni U, Speer CP, Valls-I-Soler A, Halliday H. European consensus guidelines on the Management of neonatal respiratory distress syndrome. J Perinatol Med 2007; 35: 175-86.

  41. Rojas MA, Lozano JM, Rojas MX, Laughon M, Bose CL, Rondon MA, Charry L, Bastidas JA, Perez LA, Rojas C, Ovalle O, Celis LA, Garcia-Harker J, Jaramillo ML. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: A randomized controlled trial. Pediatrics 2009; 123: 137-42.

  42. Dani C, Corsini I, Bertini G, Fontanelli G, Pratesi S, Rubaltelli F. The INSURE method in preterm infants of less than 30 weeks gestation. J Matern Fetal Neonatal Med 2010; 23: 1024-29.

  43. Soll R, Ozek E. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane Database of Systematic reviews. 2009: CD000141.

  44. Fetus and Newborn Committee Canadian Paediatric Society (CPS) (2004-2005). Recommendations for neonatal surfactant therapy. Pediatr Child Health 2005; 10: 109-16.

  45. Kattwinkel J. High versus low threshold surfactant retreatment for neonatal respiratory distress syndrome. Pediatrics 2000; 106: 282-8.

  46. Henderson-Smart DJ, Davis PG. Prophylactic methylxanthines for extubation in preterm infants. Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD000139. DOI: 10.1002/14651858.CD000139

  47. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W. Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007; 357: 1893-902.

  48. Cools F, Offringa M. Neuromuscular paralysis for newborn infants receiving mechanical ventilation. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD002773. DOI: 10.1002/14651858.CD002773.pub2

  49. Hall RW, Shbarou RM. Drugs of choice for sedation and analgesia in the neonatal ICU. Clin Perinatol 2009; 36: 215-26.

  50. Cignacco E, Hamers JP, Stoffel L. The efficacy of nonpharmacological interventions in the management of procedural pain in preterm and term neonates. A systematic literature review. Eur J Pain 2006; 11: 139-52.

  51. Bellù R, de Waal KA, Zanini R. Opioids for neonates receiving mechanical ventilation. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD004212. DOI: 10.1002/14651858.CD004212. pub3

  52. 52 Ng E, Taddio A, Ohlsson A. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD002052. DOI: 10.1002/14651858.CD002052

  53. Aranda JV, Carlo W, Hummel P, Thomas R, Lehr VT, Anand KJ. Analgesia and sedation during mechanical ventilation in neonates. Clin Ther 2005; 27: 877-99.

  54. Brion LP, Soll R. Diuretics for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD001454. DOI: 10.1002/14651858.CD001454.pub2

  55. Howlett A, Ohlsson A. Inositol for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD000366. DOI: 10.1002/14651858.CD000366

  56. Boyer KM, Gotoff SP. Antimicrobial prophylaxis of neonatal Group B streptococcal sepsis. Clin Perinatol 1988; 15: 831-50.

  57. Darlow BA, Graham PJ. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birth weight infants. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD000501. DOI: 10.1002/14651858.CD000501.pub2

  58. Osborn DA, Evans NJ. Early volume expansion for prevention of morbidity and mortality in very preterm infants. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD002055. DOI: 10.1002/14651858.CD002055.pub2.

  59. Osborn DA, Evans N. Early volume expansion versus inotrope for prevention of morbidity and mortality in very preterm infants (Cochrane Review). In: The Cochrane Library, Issue 3, 2008.

  60. Dive A, Foret F, Jamart J, Bulpa P, Installé E. Effect of dopamine on gastrointestinal motility during critical illness. Intensive Care Med 2000; 26: 901-7.

  61. Van de Borne P, Oren R, Somers VK. Dopamine depresses minute ventilation in patients with heart failure. Circulation 1998; 98: 126-31.

  62. AU. Ng PC, Lee CH, Bnur FL, Chan IH, Lee AW, Wong E, Chan HB, Lam CW, Lee BS, Fok TF. SO. A double-blind, randomized, controlled study of a “stress dose” of hydrocortisone for rescue treatment of refractory hypotension in preterm infants. Pediatrics 2006; 117: 367-75.

  63. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2008; Jan 23; (1): CD003481.

  64. Herrera C, Holberton J, Davis P. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2007; (2): CD003480.

  65. Cherif A, Khrouf N, Jabnoun S, Mokrani C, Amara M, Guellouze N, Kacem S. Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Pediatrics 2008; 122: 1256-61.

  66. Tin W, Milligan DW, Pennefather P, Hey E. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks’ gestation. Arch Dis Child Fetal Neonatal Ed 2001; 84: F106-F110.

  67. Askie LM, HeNErson-Smart DJ, Irwing L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003; 349: 959-67.

  68. Saugstad OD. Optimal oxygenation at birth and in the neonatal period. Neonatology 2007; 91: 319-22.

  69. Wright KW, Sami D, Thompson L, Ramanathan R, Joseph R, Farzavandi S. A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity. Trans Am Ophthalmol Soc 2006; 104: 78-84.

  70. Vanderveen DK, Mansfield TA, Eichenwald EC. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. JAAPOS 2006; 10: 445-8.

  71. Deulofeut R, Critz A, Adams-Chapman I, Sola A. Avoiding hyperoxia in infants £ 1,250 g is associated with improved short- and long-term outcomes. J Perinatol 2006; 26: 700-5.

  72. Lloyd J, Askie L, Smith J, Tarnow-Mordi W. Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity. Cochrane Database Syst Rev 2003; 2: CD003482.

  73. Supplemental therapeutic oxygen for pre-threshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. Primary outcomes. Pediatrics 2000; 105: 295-310.

  74. Chow LC, Wright KW, Sola A. Oxygen Administration Study Group: Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 2003; 111: 339-45.

  75. Cunningham S, Fleck BW, Elton RA, McIntosh N. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet 1995; 346: 1464-65.

  76. Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, Epstein MF, Fitzhardinge PM, Hansen CB, Hansen RN, Hosdon WA, James LS, Kitterman JA, Nielsen HC, Poirier TA, Troug WE, Wung J-T. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987; 79: 16-30.

  77. Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, Susser M, Paneta N, Levinton A, and the Neonatology Committee for Developmental Epidemiology Network. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? Pediatrics 2000; 105: 1194-1201.

  78. Rojas MA, González A, Bancalari E, Claure MS, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995; 126: 605-10.

  79. Ho JJ, Subramaniam P, HeNErson-Smart DJ, Davis PG. Presión de distensión continua de las vías respiratorias para el síndrome de dificultad respiratoria en recién nacidos prematuros (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 2. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2008 Issue 2. Chichester, UK: John Wiley & Sons, Ltd.).

  80. Ho JJ, Henderson-Smart DJ, Davis PG. Iniciación temprana versus tardía de la presión de distensión continua para el síndrome de distrés respiratorio en niños prematuros (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 2. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2008 Issue 2. Chichester, UK: John Wiley & Sons, Ltd.).

  81. Subramaniam P, Henderson-Smart DJ, Davis PG. Profilaxis con presión positiva nasal continua de las vías respiratorias para la prevención de la morbilidad y mortalidad en neonatos muy prematuros (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 2. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2008 Issue 2. Chichester, UK: John Wiley & Sons, Ltd.). Fecha de la modificación más reciente: 20 de abril de 2005 Fecha de la modificación significativa más reciente: 20 de abril de 2005.

  82. Stevens TP, Harrington EW, Blennow M, Soll RF. Administración temprana de surfactante con ventilación breve versus surfactante selectivo y VM continua para recién nacidos prematuros con o en riesgo de síndrome de dificultad respiratoria. (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 2. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2008 Issue 2. Chichester, UK: John Wiley & Sons, Ltd.). Fecha de la modificación significativa más reciente: 20 de junio.

  83. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns less than 30 weeks‘s gestation. Pediatrics 1999; 103: e24.

  84. Sandri F, Plavka R, Ancora G, Simeoni Y, Strank Z, Martinelli S, Mosca F, Nona J, Thomson M, Verder H, Fabbri L, Halliday H; for the CURPAP Study Group. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010; 125: e1402-9.

  85. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli F. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants < 30 weeks’ gestation. Pediatrics 2004; 113: e560-e563.

  86. Morley CH, Davis PG, Doyle LW, Brio LP, Hascoet J-M, Carlin JV. For the COIN Trial Investigators. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008; 358: 700-8.

  87. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, Donovan EF, Newman NS, Ambalavanan N, Frantz ID 3rd, Buchter S, Sánchez PJ, Kennedy KA, Laroia N, Poindexter BB, Cotten CM, Van Meurs KP, Duara S, Narendran V, Sood BG, O’Shea TM, Bell EF, Bhandari V, Watterberg KL, Higgins RD. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010; 362:1970-1979.

  88. Rojas MA, Lozano MJ, Rojas MX, Laughon M, Bose CL, Rondon MA, Charry L, Bastidas JA, Pérez LA, Rojas C, Ovalle O, Celis LA, García-Harke J, Jaramillo ML, for the Colombian Neonatal Research Network. Very early surfactant without mandatory ventilation en premature infants treated with early continuous positive airway pressure: a randomized controlled trial. Pediatrics 2009; 123: 137-142.

  89. Davis PG, Henderson-Smart DJ. Presión positiva nasal continua en las vías respiratorias inmediatamente después de la extubación para prevenir la morbilidad en recién nacidos. (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 2. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2008 Issue 2. Chichester, UK: John Wiley & Sons, Ltd.). Fecha de la modificación más reciente: 24 de diciembre de 2002 Fecha de la modificación significativa más reciente: 22 de noviembre de 2002.

  90. te Pas AB, Walther FH. A randomized controlled trial of delivery room respiratory management in very preterm infants. Pediatrics 2007; 120: 322-29.

  91. Ammari A, Suri M, Milisavljevic V, Sahni R, Bateman D, Sanocka U, Ruzal-Shapiro C, Wung J-T, Polin, RA. Variables associated with the early failure of nasal CPAP in very low birth weight infants. J Pediatr 2005; 147: 341-7.

  92. Sandri F, Ancora G, Lanzón A, Tagliaue P, Colnaghi M, Ventura ML, Rinalde M, Mondello I, Gancia P, Salvioli GP, Orzalesi M, Mosca F, on behalf of the Pneumology Study Group of the Italian Society of Neonatology. Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomized controlled clinical trial. Arch Dis Child Fetal Neonatal Ed 2004; 89: F394-F398: doi:10.1136/adc.2003.030701.

  93. Polin RA, Sahni R. Newer experience with CPAP. Semin Neonatol 2002; 7: 379-89.

  94. Birebaum HJ, Dentro A, Cirelli J, Helou S, Pane MA, Starr K, Melick CF, Updegraff L, Arnold C, Tamayo A, Torres V, Gungon N, Liverman S. Reduction in the incidence of chronic lung disease in very low birth weight infants: results of quality improvement process in a tertiary level neonatal intensive care unit. Pediatrics 2009; 213: 44-50.

  95. Kirchner L, Weninger M, Unterasinger L, Birnbacher R, Hayde M, Krepler R, Pollak A. Is the use of early nasal CPAP associated with lower rates of chronic lung disease and retinopathy of prematurity? Nine years of experience with the Vermont Oxford Neonatal Network. J Perinat Med 2005; 33: 60-6.

  96. Aly H, Milner J, Patel K, El-MohaNEs AAE. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants? Pediatrics 2004; 114: 697-702.

  97. Henderson-Smart DJ, Wilkinson AR, Raynes-Greenow CH. Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease. Cochrane Database of Systematic Reviews 2002, Issue 4. Art. No.: CD002770. DOI: 10.1002/14651858. CD002770. Publication status and date: Edited (no change to conclusions), published in Issue 1, 2011. Review content assessed as up-to-date: 18 March 2010.

  98. Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK. Treatment of the idiopathic respiratory distress syndrome with continuous positive airway pressure. N Engl J Med 1971; 284: 1333-40.

  99. Bhuta T, Henderson-Smart DJ. Rescue high frequency oscillatory ventilation versus conventional ventilation for pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev 2000; 2:CD000438.

  100. Halter JM, Steinberg JM, Gatto LA, DiRocco JD, Pavone LA, Schiller HJ, Scott A, Lee HM, Carney D, Nieman GF. Effect of positive end-expiratory pressure and tidal volume on lung injury induced by alveolar instability. Critical Care 2007; 11: R104.

  101. Kamlin CO, Davis PG. Long versus short inspiratory times in neonates receiving mechanical ventilation. Cochrane Database Syst Rev 2004; (4): CD004503.

  102. First Edition: 2005, Rev 3/06 ACoRN, Acute Care of at-Risk Newborns –www.acomprogram.net Copyright O 2005, 2006 ACoRN Neonatal Society, Vancouver, British Columbia, Canada - society, acornprogram.net

  103. Hermeto F, Nosralla BM, Vaillancourt K, MeNEs SG. Implementation of a respiratory therapist-driven protocol for neonatal ventilation: Impact on the premature population. Pediatrics 2009; 123: e907-e916.

  104. Erickson SJ, Grauaug A, Gurrin L, Swaminathan M. Hypocarbia in the ventilated preterm infant and its effect on intraventricular haemorrhage and bronchopulmonary dysplasia. J Paediatr Child Health 2002; 38: 560-62.

  105. Henderson-Sanart DJ, Bhuta T, Cools F, Offringa M. Ventilación oscilatoria de alta frecuencia electiva versus ventilación convencional para la disfunción pulmonar aguda en los neonatos prematuros. En: La Biblioteca Cochrane Plus, 2008, Número 2.

  106. Royal College of Paediatrics and Child Health (RCPCH) Guidelines for good practice. Management of neonatal respiratory distress syndrome. Dec 2000. Disponible en: www.pediatriconcall.com/.../GuidelinesforRDS.P

  107. British Association of Perinatal Medicine. Guidelines for good practice in the management of neonatal respiratory distress syndrome. Report of the second working group of the British Association of Perinatal Medicine. Guideline produced in November 1998, Not valid beyond 2002. Disponible en: http//www.bapm.org/publications/.../guidelines/rds.pd

  108. Barrington KJ, Finer NN. Inhaled nitric oxide for respiratory failure in preterm infants. In: Cochrane Database of Systematic Reviews, Issue 1, 2006.

  109. Wiswell TE, Tin W, Ohler K. Evidence based use of adjunctive therapies to ventilation. Clin Perinatol 2007; 34: 191-204.

  110. Henderson-Smart DJ, Davis PG. Metilxantinas profilácticas para la extubación en los neonatos prematuros (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 2. Disponible n:http://www.update software

  111. Davis PG, Henderson-Smart DJ. Intravenous dexamethasone for extubation of newborn infants (Cochrane Review). In: The Cochrane Library, Issue 3, 2008.

  112. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR. Trends in neonatal morbidity and mortality for very low birth weight infants. Am J Obstet Gynecol 2007; 196(2): 147-8.

  113. Keszler M. State of the art in conventional mechanical ventilation. J Perinat 2009; 29: 262-75.

  114. Edibam C. Ventilator-Induced lung Injury and Implications for Clinical Management. Critical Care and Resuscitation 2000; 2: 269-77.

  115. Ricard JD, Dreyfuss D, Saumon G. Ventilator-induced lung injury. Eur Respir J 2003; 22: Suppl. 42, 2s-9s.

  116. Dreyfuss D, Saumon G. Ventilator-induced lung injury. Lessons from experimental studies. Am J Respir Crit Care Med 1998: 157: 294-323

  117. Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev, 2009 Apr 15; (2): CD0078836.




2020     |     www.medigraphic.com